Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization

por Braun, Hillary J., Dodge, Jennifer L., Grab, Joshua D., Glencer, Alexa C., Schwab, Marisa E., Stock, Peter G., Hirose, Ryutaro, Roberts, John P., Ascher, Nancy L.
Publicado no Transplantation (2021)

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection

por Glencer, Alexa C., Wong, Jasmine M., Hylton, Nola M., Krings, Gregor, McCune, Emma, Rothschild, Harriet T., Loveday, Tristan A., Alvarado, Michael D., Esserman, Laura J., Campbell, Michael J.
Publicado no NPJ Breast Cancer (2021)

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer

por Rugo, Hope S., Jo Chien, A., Franco, Sandra X., Stopeck, Alison T., Glencer, Alexa, Lahiri, Soumi, Arbushites, Michael C., Scott, Janet, Park, John W., Hudis, Clifford, Nulsen, Ben, Dickler, Maura N.
Publicado em 2011

Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study (A2ALL)

por Braun, Hillary J., Grab, Joshua D., Dodge, Jennifer L., Syed, Shareef M., Roll, Garrett R., Schwab, Marisa P., Liu, Iris H., Glencer, Alexa C., Freise, Chris E., Roberts, John P., Ascher, Nancy L.
Publicado no Transplantation (2021)